BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haifer C, Saikal A, Paramsothy R, Kaakoush NO, Leong RW, Borody TJ, Kamm MA, Paramsothy S. Response to faecal microbiota transplantation in ulcerative colitis is not sustained long term following induction therapy. Gut 2020:gutjnl-2020-323581. [PMID: 33303563 DOI: 10.1136/gutjnl-2020-323581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ponce-Alonso M, García-Hoz C, Halperin A, Nuño J, Nicolás P, Martínez-Pérez A, Ocaña J, García-Pérez JC, Guerrero A, López-Sanromán A, Cantón R, Roy G, Del Campo R. An Immunologic Compatibility Testing Was Not Useful for Donor Selection in Fecal Microbiota Transplantation for Ulcerative Colitis. Front Immunol 2021;12:683387. [PMID: 34149723 DOI: 10.3389/fimmu.2021.683387] [Reference Citation Analysis]
2 Waller KMJ, Leong RW, Paramsothy S. An update on fecal microbiota transplantation for the treatment of gastrointestinal diseases. J Gastroenterol Hepatol 2021. [PMID: 34735024 DOI: 10.1111/jgh.15731] [Reference Citation Analysis]
3 Haifer C, Paramsothy S, Kaakoush NO, Saikal A, Ghaly S, Yang T, Luu LDW, Borody TJ, Leong RW. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol 2021:S2468-1253(21)00400-3. [PMID: 34863330 DOI: 10.1016/S2468-1253(21)00400-3] [Reference Citation Analysis]
4 Stojek M, Jabłońska A, Adrych K. The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease. J Clin Med 2021;10:4055. [PMID: 34575166 DOI: 10.3390/jcm10184055] [Reference Citation Analysis]